{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T10:38:20Z","timestamp":1794134300856,"version":"4.8.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s11906-020-01048-y","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T15:02:04Z","timestamp":1593183724000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Relationship Between ACE2 and Other Components of the Renin-Angiotensin System"],"prefix":"10.1007","volume":"22","author":[{"given":"Jordana B.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Hanff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam P.","family":"Bress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"South","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"1048_CR1","doi-asserted-by":"crossref","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020.","DOI":"10.1001\/jama.2020.2648"},{"key":"1048_CR2","doi-asserted-by":"crossref","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020.","DOI":"10.1056\/NEJMoa2002032"},{"key":"1048_CR3","doi-asserted-by":"crossref","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020.","DOI":"10.1001\/jama.2020.1585"},{"key":"1048_CR4","doi-asserted-by":"crossref","unstructured":"Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020.","DOI":"10.1001\/jamainternmed.2020.0994"},{"key":"1048_CR5","doi-asserted-by":"crossref","unstructured":"Sparks MA, South A, Welling P, Luther JM, Cohen J, Byrd JB, et al. Sound science before quick judgement regarding RAS blockade in COVID-19. Clin J Am Soc Nephrol. 2020.","DOI":"10.2215\/CJN.03530320"},{"key":"1048_CR6","unstructured":"\u2022 Sparks MA, Hiremath S, South A, Welling P, Luther JM, Cohen JB, et al. \u201cThe coronavirus conundrum: ACE2 and hypertension edition\u201d NephJC http:\/\/www.nephjc.com\/news\/covidace2. Accessed 13 Apr 2020. 2020. This is a multidiscplinary free open access medical education document by several physician scientists whose research focuses on the renin-angiotensin system, which provides a comprehensive overview of research related to ACE2 and COVID-19, including live updates as new research emerges. The site had >260,000 page views within its first three weeks of launching."},{"issue":"1","key":"1048_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1042\/CS20171550","volume":"133","author":"AM South","year":"2019","unstructured":"South AM, Shaltout HA, Washburn LK, Hendricks AS, Diz DI, Chappell MC. Fetal programming and the angiotensin-(1-7) axis: a review of the experimental and clinical data. Clin Sci (Lond). 2019;133(1):55\u201374.","journal-title":"Clin Sci (Lond)"},{"issue":"11","key":"1048_CR8","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1093\/ndt\/gft320","volume":"28","author":"MJ Soler","year":"2013","unstructured":"Soler MJ, Wysocki J, Batlle D. ACE2 alterations in kidney disease. Nephrol Dial Transplant. 2013;28(11):2687\u201397.","journal-title":"Nephrol Dial Transplant"},{"issue":"45","key":"1048_CR9","doi-asserted-by":"publisher","first-page":"13185","DOI":"10.1021\/bi035268s","volume":"42","author":"JL Guy","year":"2003","unstructured":"Guy JL, Jackson RM, Acharya KR, Sturrock ED, Hooper NM, Turner AJ. Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence. Biochemistry. 2003;42(45):13185\u201392.","journal-title":"Biochemistry."},{"issue":"5","key":"1048_CR10","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","volume":"87","author":"M Donoghue","year":"2000","unstructured":"Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 2000;87(5):E1\u20139.","journal-title":"Circ Res"},{"issue":"3","key":"1048_CR11","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/cphy.c130040","volume":"4","author":"MA Sparks","year":"2014","unstructured":"Sparks MA, Crowley SD, Gurley SB, Mirotsou M, Coffman TM. Classical renin-angiotensin system in kidney physiology. Compr Physiol. 2014;4(3):1201\u201328.","journal-title":"Compr Physiol"},{"issue":"1 Pt 2","key":"1048_CR12","doi-asserted-by":"publisher","first-page":"3S","DOI":"10.1016\/S0895-7061(01)02273-7","volume":"15","author":"DE Vaughan","year":"2002","unstructured":"Vaughan DE. Angiotensin and vascular fibrinolytic balance. Am J Hypertens. 2002;15(1 Pt 2):3S\u20138S.","journal-title":"Am J Hypertens"},{"key":"1048_CR13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.thromres.2015.12.008","volume":"138","author":"A Gromotowicz-Poplawska","year":"2016","unstructured":"Gromotowicz-Poplawska A, Stankiewicz A, Kramkowski K, Gradzka A, Wojewodzka-Zelezniakowicz M, Dzieciol J, et al. The acute prothrombotic effect of aldosterone in rats is partially mediated via angiotensin II receptor type 1. Thromb Res. 2016;138:114\u201320.","journal-title":"Thromb Res"},{"key":"1048_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.metabol.2019.03.006","volume":"95","author":"DF Lelis","year":"2019","unstructured":"Lelis DF, Freitas DF, Machado AS, Crespo TS, Santos SHS. Angiotensin-(1-7), adipokines and inflammation. Metabolism. 2019;95:36\u201345.","journal-title":"Metabolism"},{"issue":"8","key":"1048_CR15","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","volume":"118","author":"VB Patel","year":"2016","unstructured":"Patel VB, Zhong JC, Grant MB, Oudit GY. Role of the ACE2\/angiotensin 1-7 axis of the renin-angiotensin system in heart failure. Circ Res. 2016;118(8):1313\u201326.","journal-title":"Circ Res"},{"issue":"2","key":"1048_CR16","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1161\/HYPERTENSIONAHA.111.177485","volume":"59","author":"M Flores-Munoz","year":"2012","unstructured":"Flores-Munoz M, Work LM, Douglas K, Denby L, Dominiczak AF, Graham D, et al. Angiotensin-(1-9) attenuates cardiac fibrosis in the stroke-prone spontaneously hypertensive rat via the angiotensin type 2 receptor. Hypertension. 2012;59(2):300\u20137.","journal-title":"Hypertension."},{"issue":"5","key":"1048_CR17","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1210\/en.2006-1287","volume":"148","author":"S Wakahara","year":"2007","unstructured":"Wakahara S, Konoshita T, Mizuno S, Motomura M, Aoyama C, Makino Y, et al. Synergistic expression of angiotensin-converting enzyme (ACE) and ACE2 in human renal tissue and confounding effects of hypertension on the ACE to ACE2 ratio. Endocrinology. 2007;148(5):2453\u20137.","journal-title":"Endocrinology."},{"issue":"5","key":"1048_CR18","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/sj.ki.5002373","volume":"72","author":"MJ Soler","year":"2007","unstructured":"Soler MJ, Wysocki J, Ye M, Lloveras J, Kanwar Y, Batlle D. ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. Kidney Int. 2007;72(5):614\u201323.","journal-title":"Kidney Int"},{"issue":"2","key":"1048_CR19","doi-asserted-by":"publisher","first-page":"438","DOI":"10.2353\/ajpath.2007.060977","volume":"171","author":"DW Wong","year":"2007","unstructured":"Wong DW, Oudit GY, Reich H, Kassiri Z, Zhou J, Liu QC, et al. Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am J Pathol. 2007;171(2):438\u201351.","journal-title":"Am J Pathol"},{"issue":"5","key":"1048_CR20","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1161\/01.HYP.0000244543.91937.79","volume":"48","author":"GI Rice","year":"2006","unstructured":"Rice GI, Jones AL, Grant PJ, Carter AM, Turner AJ, Hooper NM. Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study. Hypertension. 2006;48(5):914\u201320.","journal-title":"Hypertension."},{"issue":"7047","key":"1048_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature03712","volume":"436","author":"Y Imai","year":"2005","unstructured":"Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436(7047):112\u20136.","journal-title":"Nature."},{"issue":"2","key":"1048_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2337\/db09-1218","volume":"59","author":"GY Oudit","year":"2010","unstructured":"Oudit GY, Liu GC, Zhong J, Basu R, Chow FL, Zhou J, et al. Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes. 2010;59(2):529\u201338.","journal-title":"Diabetes."},{"issue":"1","key":"1048_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1161\/HYPERTENSIONAHA.109.138420","volume":"55","author":"J Wysocki","year":"2010","unstructured":"Wysocki J, Ye M, Rodriguez E, Gonzalez-Pacheco FR, Barrios C, Evora K, et al. Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension. Hypertension. 2010;55(1):90\u20138.","journal-title":"Hypertension."},{"issue":"7","key":"1048_CR24","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.110.955369","volume":"122","author":"J Zhong","year":"2010","unstructured":"Zhong J, Basu R, Guo D, Chow FL, Byrns S, Schuster M, et al. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction. Circulation. 2010;122(7):717\u201328 18 p following 28.","journal-title":"Circulation"},{"key":"1048_CR25","doi-asserted-by":"publisher","first-page":"19840","DOI":"10.1038\/srep19840","volume":"6","author":"H Gu","year":"2016","unstructured":"Gu H, Xie Z, Li T, Zhang S, Lai C, Zhu P, et al. Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus. Sci Rep. 2016;6:19840.","journal-title":"Sci Rep"},{"issue":"20","key":"1048_CR26","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","volume":"111","author":"CM Ferrario","year":"2005","unstructured":"Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005;111(20):2605\u201310.","journal-title":"Circulation."},{"issue":"4","key":"1048_CR27","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1161\/01.HYP.0000237862.94083.45","volume":"48","author":"MP Ocaranza","year":"2006","unstructured":"Ocaranza MP, Godoy I, Jalil JE, Varas M, Collantes P, Pinto M, et al. Enalapril attenuates downregulation of angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat. Hypertension. 2006;48(4):572\u20138.","journal-title":"Hypertension."},{"issue":"5","key":"1048_CR28","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","volume":"43","author":"Y Ishiyama","year":"2004","unstructured":"Ishiyama Y, Gallagher PE, Averill DB, Tallant EA, Brosnihan KB, Ferrario CM. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension. 2004;43(5):970\u20136.","journal-title":"Hypertension."},{"issue":"2","key":"1048_CR29","doi-asserted-by":"publisher","first-page":"F398","DOI":"10.1152\/ajprenal.90488.2008","volume":"296","author":"MJ Soler","year":"2009","unstructured":"Soler MJ, Ye M, Wysocki J, William J, Lloveras J, Batlle D. Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan. Am J Physiol Ren Physiol. 2009;296(2):F398\u2013405.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"8","key":"1048_CR30","first-page":"1280","volume":"19","author":"TE Walters","year":"2017","unstructured":"Walters TE, Kalman JM, Patel SK, Mearns M, Velkoska E, Burrell LM. Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling. Europace. 2017;19(8):1280\u20137.","journal-title":"Europace."},{"key":"1048_CR31","doi-asserted-by":"crossref","unstructured":"\u2022 Ramchand J, Patel SK, Srivastava PM, Farouque O, Burrell LM. Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease. PLoS One. 2018;13(6):e0198144. This prospective observational study of 79 patients with obstructive coronary artery disease demonstrated that elevated ACE2 activity was independently associated with major adverse cardiovascular events over a median follow up of 10.5 years. The authors also observed that the frequency of elevated ACE2 activity was similar across users and non-users of ACE inhibitors and Ang II receptor blockers.","DOI":"10.1371\/journal.pone.0198144"},{"key":"1048_CR32","first-page":"e21","volume":"8","author":"M Roth","year":"2020","unstructured":"Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet. 2020;8:e21.","journal-title":"Lancet."},{"issue":"5","key":"1048_CR33","doi-asserted-by":"publisher","first-page":"H1084","DOI":"10.1152\/ajpheart.00217.2020","volume":"318","author":"AM South","year":"2020","unstructured":"South AM, Diz DI, Chappell MC. COVID-19, ACE2, and the cardiovascular consequences. Am J Physiol Heart Circ Physiol. 2020;318(5):H1084\u2013H90.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1048_CR34","first-page":"419","volume":"45","author":"NJ Brown","year":"2000","unstructured":"Brown NJ, Vaughan DE. Prothrombotic effects of angiotensin. Adv Intern Med. 2000;45:419\u201329.","journal-title":"Adv Intern Med"},{"key":"1048_CR35","doi-asserted-by":"crossref","unstructured":"\u2022 Senchenkova EY, Russell J, Yildirim A, Granger DN, Gavins FNE. Novel role of T cells and IL-6 (interleukin-6) in angiotensin II-induced microvascular dysfunction. Hypertension. 2019;73(4):829\u201338. Using several mouse models, this study demonstrated that T cell IL-6 mediates the thrombotic abnormalities found in hypertension via the ACE\/Ang II pathway. Additionally, using human samples, the authors found that IL-6 promotes platelet aggregation, leading to increased risk of thrombosis.","DOI":"10.1161\/HYPERTENSIONAHA.118.12286"},{"key":"1048_CR36","doi-asserted-by":"crossref","unstructured":"Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020.","DOI":"10.1001\/jamacardio.2020.1286"},{"issue":"1","key":"1048_CR37","doi-asserted-by":"publisher","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","volume":"292","author":"PK Mehta","year":"2007","unstructured":"Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Phys Cell Phys. 2007;292(1):C82\u201397.","journal-title":"Am J Phys Cell Phys"},{"issue":"8","key":"1048_CR38","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","volume":"11","author":"K Kuba","year":"2005","unstructured":"Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11(8):875\u20139.","journal-title":"Nat Med"},{"issue":"6","key":"1048_CR39","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1161\/HYPERTENSIONAHA.114.03743","volume":"64","author":"MR Deshotels","year":"2014","unstructured":"Deshotels MR, Xia H, Sriramula S, Lazartigues E, Filipeanu CM. Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism. Hypertension. 2014;64(6):1368\u201375.","journal-title":"Hypertension."}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-020-01048-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11906-020-01048-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-020-01048-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T06:09:18Z","timestamp":1744178958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11906-020-01048-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["1048"],"URL":"https:\/\/doi.org\/10.1007\/s11906-020-01048-y","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,26]]},"assertion":[{"value":"26 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflicts of interest relevant to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"44"}}